Drug Hunter has selected RGN6024 as one of its Molecules of the Month for May 2025

We’re honored that Drug Hunter has selected RGN6024 as one of its Molecules of the Month for May 2025.

This recognition highlights RGN6024’s potential as a brain-penetrant therapy for the treatment of glioblastoma, one of the most aggressive and intractable brain cancers. We’re proud to be featured alongside other innovative programs advancing therapeutic frontiers.

Thank you to Drug Hunter for the spotlight—and to our team and partners working to make breakthroughs like this possible.

Click here for the full article.